… been explored for the treatment of coronavirus disease-19 (COVID-19). Although placebo-…
indicator that IVIG immunotherapy could benefit severe and critically ill COVID-19 patients. …

… this systematic review, immunotherapy is an efficient therapeutic option intervention against
COVID-19 and the main methods in this regard such as using immunoglobulins and plasma …

… Recently, we showed that intravenous immunoglobulin (IVIg) treatment reduces …
Immunotherapy with IVIg could be employed to neutralize COVID-19. However, the efficacy …

… Several mechanisms contribute to the anti-inflammatory effects of IVIG … IVIG in three patients
with severe COVID-19 pneumonia. This study reported the application of high-dose IVIG, at …

… IVIG therapy has also been investigated in COVID-19 patients. Treating COVID-19 patients
with IVIG has been shown to improve oxygenation, reduce the length of hospital stay, and …

… Clinical efficacy may be driven by the anti-inflammatory action of IVIg, associated with its
anti… with COVID-19-related encephalopathy, we believe that immunotherapy with IVIg or other …

… It reports observations on 522 patients with confirmed CoViD-19 … immunoglobulin and
mucin domain 3 (Tim-3) as patients (n=14) deteriorated from prodromal to symptomatic CoViD-19 …

… Hence, immunotherapies based on inflammatory cytokine neutralisation and immunomodulation
could reduce inflammation and inflammation-associated lung damage. Targeted …

… characterize the early immune response to COVID-19 that causes severe lung damage and
… immunotherapies as an adjunct therapy in severe COVID-19 cases. Such immunotherapies …

… The underpinning biology with immunoglobulin therapies is the provision of immediate
antiviral humoral immunity that on the one hand reduces the viral load, and on the other hand …